newsfilter
← Latest News
GlobeNewswire·

ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update

2Q 2025 Total Revenue of $122.0 Million, a 14% YoY Increase, and a 29% YoY Increase Excluding a Prior Year Non-Recurring Item 2Q 2025 GAAP Net Income of $34.2 Million, a 7% YoY Increase 2Q 2025 Adjusted EBITDA(1) of